{"id":39033,"date":"2026-05-26T10:22:17","date_gmt":"2026-05-26T08:22:17","guid":{"rendered":"https:\/\/ggba.swiss\/neurosoft-bioelectronics-raises-usd-7-5-million-to-advance-its-brain-interface-platform\/"},"modified":"2026-05-26T10:41:41","modified_gmt":"2026-05-26T08:41:41","slug":"neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/","title":{"rendered":"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour son interface c\u00e9r\u00e9brale"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.neurosoft-bio.com\/\">Neurosoft Bioelectronics<\/a>, la start-up genevoise de neurotechnologie sp\u00e9cialis\u00e9e dans les interfaces cerveau-ordinateur souples et extensibles, a lev\u00e9 USD 7,5 millions dans un tour de seed sursouscrit. Le tour a \u00e9t\u00e9 men\u00e9 par <a href=\"https:\/\/skybound.vc\/\">Skybound Venture Capital<\/a>, avec la participation de <a href=\"https:\/\/protocol.ai\/\">Protocol Labs<\/a>, <a href=\"https:\/\/www.iagcapitalpartners.com\/\">IAG Capital Partners<\/a> et <a href=\"https:\/\/ctinnovations.com\/\">Connecticut Innovations<\/a>. Cela porte le financement total de Neurosoft \u00e0 plus de USD 20 million, t\u00e9moignant d&rsquo;une confiance durable des investisseurs dans la trajectoire clinique et le positionnement de l&rsquo;entreprise.<\/p>\n\n\n\n<p>Fond\u00e9e en tant que spin-off de l&rsquo;<a href=\"https:\/\/www.epfl.ch\/fr\/\">EPFL<\/a> et dont le si\u00e8ge est \u00e9tabli au <a href=\"https:\/\/campusbiotech.ch\/fr\/\">Campus Biotech<\/a> \u00e0 Gen\u00e8ve, Neurosoft d\u00e9veloppe des interfaces c\u00e9r\u00e9brales minimalement invasives bas\u00e9es sur des \u00e9lectrodes souples et extensibles jusqu&rsquo;\u00e0 1&rsquo;000 fois plus souples que celles utilis\u00e9es dans d&rsquo;autres interfaces neurales flexibles, et couvrant jusqu&rsquo;\u00e0 30 fois plus de cortex que les interfaces cerveau-ordinateur de pointe. L&rsquo;entreprise a d\u00e9sormais test\u00e9 sa technologie sur 10 patients dans le cadre de deux essais cliniques en cours \u00e0 UTHealth Houston et \u00e0 l&rsquo;UMC Utrecht, dont la premi\u00e8re \u00e9tude mondiale d&rsquo;interface c\u00e9r\u00e9brale souple et extensible \u00e0 64 canaux pour le guidage chirurgical de l&rsquo;\u00e9pilepsie, d\u00e9j\u00e0 couverte dans <a href=\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-fait-progresser-la-technologie-des-interfaces-cerebrales-pour-lepilepsie-et-les-acouphenes\/\">notre pr\u00e9c\u00e9dent article<\/a>. Neurosoft d\u00e9tient plus de 25 brevets, a publi\u00e9 dans plus de 25 revues scientifiques \u00e0 comit\u00e9 de lecture, exploite une ligne de fabrication GMP en Suisse et d\u00e9tient la certification ISO 13485.<\/p>\n\n\n\n<p>Le financement seed soutiendra deux jalons \u00e0 court terme : la d\u00e9monstration d&rsquo;un d\u00e9ploiement minimalement invasif chez des patients humains et la commercialisation aux \u00c9tats-Unis du premier produit d&rsquo;interface c\u00e9r\u00e9brale de Neurosoft. L&rsquo;entreprise a \u00e9tabli une pr\u00e9sence \u00e0 New York et a re\u00e7u des retours de la FDA lors de plusieurs r\u00e9unions de pr\u00e9-soumission ayant orient\u00e9 sa voie r\u00e9glementaire.<\/p>\n\n\n\n<p>Au-del\u00e0 de ses objectifs cliniques, Neurosoft d\u00e9veloppe un mod\u00e8le de fondation cortical, une IA \u00e0 grande \u00e9chelle entra\u00een\u00e9e sur des enregistrements neuronaux de haute qualit\u00e9 collect\u00e9s via ses dispositifs implantables, en appliquant la m\u00eame logique que les grands mod\u00e8les de langage entra\u00een\u00e9s sur des corpus de textes. Ce mod\u00e8le vise \u00e0 red\u00e9finir ce que les interfaces cerveau-ordinateur peuvent apporter aux patients souffrant de troubles neurologiques s\u00e9v\u00e8res, et \u00e0 positionner les interfaces c\u00e9r\u00e9brales comme une couche de communication universelle entre les humains et les machines. Neurosoft a par ailleurs annonc\u00e9 un partenariat avec <a href=\"https:\/\/science.xyz\/\">Science Corp<\/a> pour acc\u00e9l\u00e9rer davantage le d\u00e9veloppement de sa plateforme BCI.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour avancer sa plateforme d&rsquo;interface c\u00e9r\u00e9brale et son mod\u00e8le d&rsquo;IA cortical.<\/p>\n","protected":false},"author":6,"featured_media":39030,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1154,1181,1163,1239],"class_list":["post-39033","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-investment-fr-2","tag-medical-devices-fr","tag-medtech-fr-2","tag-neuroscience-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions | GGBa<\/title>\n<meta name=\"description\" content=\"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour avancer sa plateforme d&#039;interface c\u00e9r\u00e9brale et son mod\u00e8le d&#039;IA cortical.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions | GGBa\" \/>\n<meta property=\"og:description\" content=\"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour avancer sa plateforme d&#039;interface c\u00e9r\u00e9brale et son mod\u00e8le d&#039;IA cortical.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-26T08:22:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-26T08:41:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/05\/Neurosoft-Bioelectronics-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour son interface c\u00e9r\u00e9brale\",\"datePublished\":\"2026-05-26T08:22:17+00:00\",\"dateModified\":\"2026-05-26T08:41:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/\"},\"wordCount\":427,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/05\/Neurosoft-Bioelectronics-1180x811-1.jpeg\",\"keywords\":[\"Artificial Intelligence\",\"Investment\",\"Medical Devices\",\"Medtech\",\"Neuroscience\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/\",\"name\":\"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/05\/Neurosoft-Bioelectronics-1180x811-1.jpeg\",\"datePublished\":\"2026-05-26T08:22:17+00:00\",\"dateModified\":\"2026-05-26T08:41:41+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour avancer sa plateforme d'interface c\u00e9r\u00e9brale et son mod\u00e8le d'IA cortical.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/05\/Neurosoft-Bioelectronics-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/05\/Neurosoft-Bioelectronics-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"Les co-fondateurs de Neurosoft Bioelectronics, dont la technologie d'interface c\u00e9r\u00e9brale souple et extensible a d\u00e9sormais \u00e9t\u00e9 test\u00e9e sur 10 patients dans le cadre de deux essais cliniques en cours aux \u00c9tats-Unis et en Europe. | \u00a9 Neurosoft Bioelectronics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour son interface c\u00e9r\u00e9brale\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions | GGBa","description":"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour avancer sa plateforme d'interface c\u00e9r\u00e9brale et son mod\u00e8le d'IA cortical.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/","og_locale":"fr_FR","og_type":"article","og_title":"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions | GGBa","og_description":"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour avancer sa plateforme d'interface c\u00e9r\u00e9brale et son mod\u00e8le d'IA cortical.","og_url":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-05-26T08:22:17+00:00","article_modified_time":"2026-05-26T08:41:41+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/05\/Neurosoft-Bioelectronics-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour son interface c\u00e9r\u00e9brale","datePublished":"2026-05-26T08:22:17+00:00","dateModified":"2026-05-26T08:41:41+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/"},"wordCount":427,"image":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/05\/Neurosoft-Bioelectronics-1180x811-1.jpeg","keywords":["Artificial Intelligence","Investment","Medical Devices","Medtech","Neuroscience"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/","url":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/","name":"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/05\/Neurosoft-Bioelectronics-1180x811-1.jpeg","datePublished":"2026-05-26T08:22:17+00:00","dateModified":"2026-05-26T08:41:41+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour avancer sa plateforme d'interface c\u00e9r\u00e9brale et son mod\u00e8le d'IA cortical.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/05\/Neurosoft-Bioelectronics-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/05\/Neurosoft-Bioelectronics-1180x811-1.jpeg","width":1180,"height":811,"caption":"Les co-fondateurs de Neurosoft Bioelectronics, dont la technologie d'interface c\u00e9r\u00e9brale souple et extensible a d\u00e9sormais \u00e9t\u00e9 test\u00e9e sur 10 patients dans le cadre de deux essais cliniques en cours aux \u00c9tats-Unis et en Europe. | \u00a9 Neurosoft Bioelectronics"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/neurosoft-bioelectronics-leve-usd-75-millions-pour-son-interface-cerebrale\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Neurosoft Bioelectronics l\u00e8ve USD 7,5 millions pour son interface c\u00e9r\u00e9brale"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39033","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=39033"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39033\/revisions"}],"predecessor-version":[{"id":39035,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39033\/revisions\/39035"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/39030"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=39033"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=39033"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=39033"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}